CSIRO scientists helped develop this insect-resistant cotton variety, using a gene derived from a soil bacteria, Bacillus ...

Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is estimated to affect about one in 20 000 individuals1 yet, until now, people ...

Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...

A new study published in Nature Aging has uncovered new molecular signatures of frontotemporal dementia by analyzing over ...

Myriad Genetics, Inc. (NASDAQ: MYGN) is making waves at the 2025 ASCO Annual Meeting, presenting seven new research studies ...

In addition to the MRD oral abstract, additional research highlights include: “We have an exciting, diverse, and sizable slate of oncology results being presented at ASCO this year, where each ...

A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research ...

Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from 6-8 weeks, to as little as two hours.The team ...

Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it ...

Get Instant Summarized Text (Gist) A 23-SNP molecular assay enables rapid and precise diagnosis of Alpha-1 Antitrypsin Deficiency (AATD), a major genetic cause of COPD, by detecting 20 pathogenic ...

While more validation and testing will be needed, this method could offer a new way to diagnose cancer or some other disorders at very early stages, and in a non-invasive way. Diseases that are in ...

SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that the Journal of Clinical ...